Pain Patches Market Trends

  • Report ID: 5783
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Pain Patches Market Trends

Growth Drivers

  • Rising occurrence of chronic pain - According to estimates, the burden of chronic pain has increased to 1.9 billion people worldwide who suffer from recurrent tension-type headaches, the most common symptom of chronic diseases. Therefore, pain patches are used to treat moderate to severe chronic pain when ongoing pain management is necessary for an extended period. As a result, with the number of cases of chronic and other illness-related pain rises, so the demand for pain patches to help patients with pain relief and support market grow.
  • Rising aged population - As per the World Health Organization, by 2050, the number of individuals over 80 is expected to triple globally, with the age distribution over 65 years increasing to 36%. This is due to both the aging population and the potential for longer lifespans. Given that 80% of nursing homes and 73% of older people who live in communities report suffering pain regularly, there may be a risk of age-related discomfort. Research indicates that not just chronic pain but also acute pain is not well managed in this group of people.
     
  • Increase in incidence of sport & work-related trauma injuries - In recent years, there has been a sharp increase in the number of people participating in physically demanding sports and jobs and are possibly risky. These elements raise the chances of chronic illnesses like tendinitis and carpal tunnel syndrome as well as acute injuries including fractures, strains, and sprains. There is a direct correlation between the number of people participating in these activities and the risk of injury. There is an increasing need for easy-to-use, non-invasive pain management options as a result of these accidents. By administering medication directly to the site of pain without the need for oral medication or intrusive procedures, pain patches provide a tailored approach to pain management.

Challenges

  • Availability of alternatives - Engaging in physical activities can improve efficiency and standard of life while improving safety and reducing the degree of pain. Patients with complex regional pain syndrome with pain and function (CRPS) have been found to benefit from several physical therapy treatments, including graded motor imagery (GMI) and mirror therapy.

    Additionally, the benefits of GMI and mirror treatment for phantom limb pain were found. As a result, it is anticipated that the availability of various alternative therapies, including chiropractic adjustments, acupuncture, and pain management devices, will reduce the need for pain patches because they have no negative side effects and will prevent the market from growing.
  • Limited efficacy may hinder market growth.
  • Patent expiration in this field may hamper the growth of the market.

Pain Patches Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

4.7%

Base Year Market Size (2024)

USD 5.39 billion

Forecast Year Market Size (2037)

USD 9.79 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5783
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of pain patches is estimated at USD 5.59 billion.

The pain patches market size was valued at USD 5.39 billion in 2024 and is likely to cross USD 9.79 billion by 2037, expanding at more than 4.7% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by increase in instances of chronic diseases, and the surge in demand for less side effect-prone pain medications.

North America industry is poised to hold largest revenue share of 32% by 2037, due to rising participation in sport-related activities among people in the region.

The major players in the market include Endo, Inc., Johnson and Johnson Private Limited, Sorrento Therapeutics, Inc., Amneal Pharmaceuticals LLC, Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Grunenthal GmbH, NEXGEL, Inc., Viatris Inc., Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample